These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 12062926)
1. A comparison of Haber's rule at different ages using a physiologically based pharmacokinetic (PBPK) model for chloroform in rats. Evans MV; Boyes WK; Simmons JE; Litton DK; Easterling MR Toxicology; 2002 Jul; 176(1-2):11-23. PubMed ID: 12062926 [TBL] [Abstract][Full Text] [Related]
2. Haber's rule: a special case in a family of curves relating concentration and duration of exposure to a fixed level of response for a given endpoint. Miller FJ; Schlosser PM; Janszen DB Toxicology; 2000 Aug; 149(1):21-34. PubMed ID: 10963858 [TBL] [Abstract][Full Text] [Related]
3. A comparison of Reduced Life Expectancy (RLE) model with Haber's Rule to describe effects of exposure time on toxicity. Verma V; Yu QJ; Connell DW Environ Pollut; 2015 Sep; 204():26-31. PubMed ID: 25898234 [TBL] [Abstract][Full Text] [Related]
4. Dose-based duration adjustments for the effects of inhaled trichloroethylene on rat visual function. Boyes WK; Bercegeay M; Ali JS; Krantz T; McGee J; Evans M; Raymer JH; Bushnell PJ; Simmons JE Toxicol Sci; 2003 Nov; 76(1):121-30. PubMed ID: 12915717 [TBL] [Abstract][Full Text] [Related]
5. The use of Haber's law in standard setting and risk assessment. Gaylor DW Toxicology; 2000 Aug; 149(1):17-9. PubMed ID: 10963857 [TBL] [Abstract][Full Text] [Related]
6. Estimation of chloroform inhalation dose by other routes based on the relationship of area under the blood concentration-time curve (AUC)-inhalation dose to chloroform distribution in the blood of rats. Take M; Takeuchi T; Haresaku M; Matsumoto M; Nagano K; Yamamoto S; Takamura-Enya T; Fukushima S J Environ Sci Health A Tox Hazard Subst Environ Eng; 2014; 49(3):253-61. PubMed ID: 24279616 [TBL] [Abstract][Full Text] [Related]
7. Application of an updated physiologically based pharmacokinetic model for chloroform to evaluate CYP2E1-mediated renal toxicity in rats and mice. Sasso AF; Schlosser PM; Kedderis GL; Genter MB; Snawder JE; Li Z; Rieth S; Lipscomb JC Toxicol Sci; 2013 Feb; 131(2):360-74. PubMed ID: 23143927 [TBL] [Abstract][Full Text] [Related]
8. The role of time as a quantifiable variable of toxicity and the experimental conditions when Haber's c x t product can be observed: implications for therapeutics. Rozman KK; Doull J J Pharmacol Exp Ther; 2001 Mar; 296(3):663-8. PubMed ID: 11181890 [TBL] [Abstract][Full Text] [Related]
9. Moving from external exposure concentration to internal dose: duration extrapolation based on physiologically based pharmacokinetic derived estimates of internal dose. Simmons JE; Evans MV; Boyes WK J Toxicol Environ Health A; 2005 Jun 11-25; 68(11-12):927-50. PubMed ID: 16020185 [TBL] [Abstract][Full Text] [Related]
10. Concentration × time analyses of sensory irritants revisited: Weight of evidence or the toxic load approach. That is the question. Pauluhn J Toxicol Lett; 2019 Nov; 316():94-108. PubMed ID: 31499141 [TBL] [Abstract][Full Text] [Related]
11. A distributed parameter physiologically-based pharmacokinetic model for dermal and inhalation exposure to volatile organic compounds. Roy A; Weisel CP; Lioy PJ; Georgopoulos PG Risk Anal; 1996 Apr; 16(2):147-60. PubMed ID: 8638037 [TBL] [Abstract][Full Text] [Related]
12. Chloroform inhalation exposure conditions necessary to initiate liver toxicity in female B6C3F1 mice. Constan AA; Wong BA; Everitt JI; Butterworth BE Toxicol Sci; 2002 Apr; 66(2):201-8. PubMed ID: 11896286 [TBL] [Abstract][Full Text] [Related]
13. Concentration-time relationships for the effects of inhaled trichloroethylene on signal detection behavior in rats. Bushnell PJ Fundam Appl Toxicol; 1997 Mar; 36(1):30-8. PubMed ID: 9073464 [TBL] [Abstract][Full Text] [Related]
14. Validation of Haber's Rule (dose x time = constant) in rats and mice for monochloroacetic acid and 2,3,7,8-tetrachlorodibenzo-p-dioxin under conditions of kinetic steady state. Saghir SA; Lebofsky M; Pinson DM; Rozman KK Toxicology; 2005 Nov; 215(1-2):48-56. PubMed ID: 16076519 [TBL] [Abstract][Full Text] [Related]
15. The utility of PBPK in the safety assessment of chloroform and carbon tetrachloride. Delic JI; Lilly PD; MacDonald AJ; Loizou GD Regul Toxicol Pharmacol; 2000 Oct; 32(2):144-55. PubMed ID: 11067771 [TBL] [Abstract][Full Text] [Related]
16. Delayed acute toxicity of 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin (HpCDD), after oral administration, Obeys Haber's rule of inhalation toxicology. Rozman KK Toxicol Sci; 1999 May; 49(1):102-9. PubMed ID: 10367347 [TBL] [Abstract][Full Text] [Related]
17. Global optimization of the Michaelis-Menten parameters using physiologically-based pharmacokinetic (PBPK) modeling and chloroform vapor uptake data in F344 rats. Evans MV; Eklund CR; Williams DN; Sey YM; Simmons JE Inhal Toxicol; 2020 Feb; 32(3):97-109. PubMed ID: 32241199 [No Abstract] [Full Text] [Related]
18. Does Haber's law apply to human sensory irritation? Shusterman D; Matovinovic E; Salmon A Inhal Toxicol; 2006 Jun; 18(7):457-71. PubMed ID: 16603477 [TBL] [Abstract][Full Text] [Related]
19. Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling. Reitz RH; Mendrala AL; Corley RA; Quast JF; Gargas ML; Andersen ME; Staats DA; Conolly RB Toxicol Appl Pharmacol; 1990 Sep; 105(3):443-59. PubMed ID: 2237918 [TBL] [Abstract][Full Text] [Related]
20. Bayesian estimation of pharmacokinetic and pharmacodynamic parameters in a mode-of-action-based cancer risk assessment for chloroform. Liao KH; Tan YM; Conolly RB; Borghoff SJ; Gargas ML; Andersen ME; Clewell HJ Risk Anal; 2007 Dec; 27(6):1535-51. PubMed ID: 18093051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]